journal article·2023-01-27

Ag2–3xBixS Quantum Dots as Single-Component Theranostic Agents for Second Near-Infrared Fluorescence Imaging-Guided Photothermal Therapy

Di Cui, Lixia Han, Wei Jiang, Ligang Chen, Na Niu

ACS Applied Nano Materials· Volume 6· Issue 2
Publisher page

Abstract

Silver sulfide (Ag 2 S) nanomaterials are being researched increasingly because of their multifunctional potential in the second near-infrared (NIR-II) region (1000–1500 nm). Here, we report Ag 2–3 x Bi x S quantum dots (Ag 2–3 x Bi x S QDs) as single-component theranostic nanomaterials for NIR-II fluorescence imaging and synchronous photothermal therapy. Bismuth doping in Ag 2 S QDs leads to a fluorescence red shift to the NIR-II region and simultaneously enhances the photothermal conversion efficiency to 58.9%, which can be ascribed to the altered band gap introduced by bismuth doping. This Ag 2 S-based NIR-II theranostic agent can be synthesized in a controlled manner by an albumin biomineralization method under mild conditions. The encapsulation of the biomacromolecular albumin endowed Ag 2–3 x Bi x S QDs with greatly strengthened biocompatibility and stability. The survival rate of cancer cells was only 13% after irradiation with an 808 nm laser at a density of 1.2 W cm –2 for 10 min. Meanwhile, in vivo experiments have confirmed the desirable NIR-II fluorescence imaging capability of Ag 2–3 x Bi x S QDs. Thus, this study provides a highly efficient single-component theranostic agent with great promise for application in the field of precision theranostics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Quantum Dots Synthesis And Properties · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Forest Plant Ecology, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin150040, China

Funding

Natural Science Foundation of Heilongjiang Province · Higher Education Discipline Innovation Project · Heilongjiang Touyan Innovation Team Program

References (62)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.3322/caac.2149210.3322/caac.21492 ↗
3. 10.1186/s13045-021-01096-010.1186/s13045-021-01096-0 ↗
4. 10.1021/acsami.2c0527610.1021/acsami.2c05276 ↗
5. 10.1016/j.biomaterials.2018.01.04710.1016/j.biomaterials.2018.01.047 ↗
6. 10.1021/acsnano.1c0724110.1021/acsnano.1c07241 ↗
7. 10.1016/j.nantod.2022.10142710.1016/j.nantod.2022.101427 ↗
8. 10.1007/s42765-022-00210-210.1007/s42765-022-00210-2 ↗
9. 10.1021/cr300213b10.1021/cr300213b ↗
10. 10.1002/smll.20160063510.1002/smll.201600635 ↗
11. 10.1021/acsnano.9b0813310.1021/acsnano.9b08133 ↗
12. 10.1002/smll.20210307210.1002/smll.202103072 ↗
13. 10.1002/advs.20190344110.1002/advs.201903441 ↗
14. 10.1016/j.biomaterials.2017.06.03310.1016/j.biomaterials.2017.06.033 ↗
15. 10.1021/acsanm.0c0059810.1021/acsanm.0c00598 ↗
16. 10.1021/acsanm.1c0074410.1021/acsanm.1c00744 ↗
17. 10.1021/ja909490r10.1021/ja909490r ↗
18. 10.1016/j.biomaterials.2012.03.05910.1016/j.biomaterials.2012.03.059 ↗
19. 10.1021/nn507118310.1021/nn5071183 ↗
20. 10.1002/smll.20150099710.1002/smll.201500997 ↗
21. 10.1021/acsami.1c1934410.1021/acsami.1c19344 ↗
22. 10.1002/anie.20190564310.1002/anie.201905643 ↗
23. 10.1021/acsami.0c1485510.1021/acsami.0c14855 ↗
24. 10.1039/C7CC09266K10.1039/C7CC09266K ↗
25. 10.1021/acsnano.6b0786610.1021/acsnano.6b07866 ↗
26. 10.1002/adhm.20160054510.1002/adhm.201600545 ↗
27. 10.1016/j.actbio.2020.08.00710.1016/j.actbio.2020.08.007 ↗
28. 10.1016/j.cej.2020.12577710.1016/j.cej.2020.125777 ↗
29. 10.1021/acsanm.1c0190310.1021/acsanm.1c01903 ↗
30. 10.1038/nnano.2009.32610.1038/nnano.2009.326 ↗
31. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
32. 10.1016/S1872-2067(14)60075-910.1016/S1872-2067(14)60075-9 ↗
33. 10.1021/cs401025u10.1021/cs401025u ↗
34. 10.1021/acsanm.1c0059210.1021/acsanm.1c00592 ↗
35. 10.1039/C9CS00283A10.1039/C9CS00283A ↗
36. 10.1021/nn506137n10.1021/nn506137n ↗
37. 10.1021/acsnano.1c0835010.1021/acsnano.1c08350 ↗
38. 10.1021/acsnano.7b0047610.1021/acsnano.7b00476 ↗
39. 10.1021/acsami.5b0152110.1021/acsami.5b01521 ↗
40. 10.1016/j.cej.2019.12325510.1016/j.cej.2019.123255 ↗
41. 10.3389/fbioe.2020.58563110.3389/fbioe.2020.585631 ↗
42. 10.1039/C5TC04333F10.1039/C5TC04333F ↗
43. 10.1002/smll.20120037610.1002/smll.201200376 ↗
44. 10.1021/acsami.6b0473810.1021/acsami.6b04738 ↗
45. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
46. 10.1002/adma.20150022910.1002/adma.201500229 ↗
47. 10.1002/adfm.20160134110.1002/adfm.201601341 ↗
48. 10.1002/smll.20170252910.1002/smll.201702529 ↗
49. 10.1039/c2jm31959d10.1039/c2jm31959d ↗
50. 10.1039/C7NR07263E10.1039/C7NR07263E ↗
51. 10.1021/ja208955310.1021/ja2089553 ↗
52. 10.1021/acsami.6b0776810.1021/acsami.6b07768 ↗
53. 10.1016/j.isci.2020.10157810.1016/j.isci.2020.101578 ↗
54. 10.1021/jp501266d10.1021/jp501266d ↗
55. 10.3390/biomedicines903030510.3390/biomedicines9030305 ↗
56. 10.1002/anie.20170568510.1002/anie.201705685 ↗
57. 10.1016/j.actbio.2022.04.01310.1016/j.actbio.2022.04.013 ↗
58. 10.1016/j.ccr.2021.21421810.1016/j.ccr.2021.214218 ↗
59. 10.1007/s42765-022-00191-210.1007/s42765-022-00191-2 ↗
60. 10.1007/s42765-022-00199-810.1007/s42765-022-00199-8 ↗
61. 10.2147/IJN.S8649510.2147/IJN.S86495 ↗
62. 10.1111/j.1582-4934.2007.00167.x10.1111/j.1582-4934.2007.00167.x ↗